MedPath

Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients

Phase 4
Recruiting
Conditions
Radiodermatitis
Acute
Registration Number
NCT05285943
Lead Sponsor
Cairo University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
132
Inclusion Criteria

Inclusion Criteria:<br><br> - Histological confirmation of breast malignancy,<br><br> - Surgical intervention for carcinoma of the breast with or without lymph node<br> metastasis.<br><br> - Treatment with planned course of radiation therapy 5 days a week for 3-6 weeks.<br><br> - Good Eastern Cooperative Oncology Group (ECOG) performance status (0 or 1).<br><br> - Total radiation dose of =42 Gy.<br><br>Exclusion Criteria:<br><br> - Pregnant and lactating mothers.<br><br> - Previous radiation to the chest or breast area.<br><br> - Concomitant chemotherapy.<br><br> - Concomitant medication that may cause skin reactions.<br><br> - Use of any other product on the skin at the treatment site at any time of the study.<br><br> - Active dermatitis, history of autoimmune and connective tissue diseases, skin<br> inflammatory diseases or any other specific skin disease.<br><br> - Treatment with local or oral corticosteroid, or antioxidant medications.<br><br> - Allergy to olive oil.<br><br> - Inflammatory carcinoma of the breast as well as those with a known allergy to olive<br> oil.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acute Radiation Dermatitis (ARD) grading
Secondary Outcome Measures
NameTimeMethod
Quality of Life questionnaire;Patient Satisfaction
© Copyright 2025. All Rights Reserved by MedPath